HCW Biologics announces special shareholder meeting
HCWB•Special shareholder meeting scheduled for Oct. 27
HCW Biologics will hold a virtual special shareholder meeting on Oct. 27, 2026.
Shareholders are scheduled to vote on issuing Common Warrants exercisable for up to 618,682 common shares at USD 2.59 per share.
Amended performance-based equity incentive plan to be considered
Shareholders will also consider an amended performance-based equity incentive plan, adding a 2,500,000-share Special Reserve for milestone-based grants.
